Rosenquist C J, Lindfors K K
Department of Radiology, University of California, Davis, School of Medicine, Sacramento 95817.
Radiology. 1994 Jun;191(3):647-50. doi: 10.1148/radiology.191.3.8184041.
To evaluate the cost-effectiveness of screening mammography in women 40-49 years old.
A Markov model compared two hypothetical groups; one underwent screening mammography and the other, observation without mammography. Variables tested included frequency of mammography, reduction in breast cancer mortality, and cost-effectiveness by age group. Results were expressed as marginal cost per year of life saved.
If the estimated mortality reduction from mammographic screening was 15% or greater, the marginal cost per year of life saved was comparable to that of other generally accepted medical procedures. Annual screening with an assumed 30% reduction in mortality had a cost-effectiveness similar to that of biennial screening with a 20% reduction. Screening mammography was less cost-effective in the 40-49-year-old age group than in women aged 50-79 years but more cost-effective than in those aged 80-84 years.
Although the parameters for screening mammography in women aged 40-49 years are not known with certainty, the results of this analysis may help establish priorities for utilization of medical resources.
评估40 - 49岁女性乳腺钼靶筛查的成本效益。
采用马尔可夫模型比较两个假设组;一组接受乳腺钼靶筛查,另一组不进行钼靶检查仅观察。测试的变量包括钼靶检查频率、乳腺癌死亡率降低情况以及按年龄组划分的成本效益。结果以每挽救一年生命的边际成本表示。
如果钼靶筛查估计的死亡率降低15%或更多,那么每挽救一年生命的边际成本与其他普遍接受的医疗程序相当。假设死亡率降低30%的年度筛查的成本效益与死亡率降低20%的两年一次筛查相似。40 - 49岁年龄组的乳腺钼靶筛查成本效益低于50 - 79岁的女性,但高于80 - 84岁的女性。
尽管40 - 49岁女性乳腺钼靶筛查的参数尚不确定,但该分析结果可能有助于确定医疗资源利用的优先顺序。